Showing results (11-20 of 44) with videos related to
Sort By:
Pageof 5
Tissue Antigens|April 1, 1978
Association of HLA antigen a9 with progressive systemic sclerosis (scleroderma)P J Clements, G Opelz, P I Terasaki, et al.Chest|November 1, 1989
Elevated BAL fluid histamine levels and parenchymal pulmonary disease in rheumatoid arthritisT B Casale, M M Little, D Furst, et al.Clinical Pharmacology and Therapeutics|May 1, 1988
The pharmacokinetics of etodolac in serum and synovial fluid of patients with arthritisM Kraml, D R Hicks, M McKean, et al.Clinical and Experimental Immunology|September 1, 1979
Quantitation and characterization of soluble immune complexes precipitated from sera by polyethylene glycol (PEG)D Chia, E V Barnett, J Yamagata, et al.Computers in Biology and Medicine|February 26, 2015
Assessing diagnostic complexity: An image feature-based strategy to reduce annotation costsJose R Zamacona, Ronald Niehaus, Alexander Rasin, et al.The Cochrane Database of Systematic Reviews|May 5, 2000
Prazosin for Raynaud's phenomenon in progressive systemic sclerosisJ Pope, D Fenlon, A Thompson, et al.The Cochrane Database of Systematic Reviews|May 5, 2000
Cyclofenil for Raynaud's phenomenon in progressive systemic sclerosisJ Pope, D Fenlon, A Thompson, et al.The Cochrane Database of Systematic Reviews|May 5, 2000
Iloprost and cisaprost for Raynaud's phenomenon in progressive systemic sclerosisJ Pope, D Fenlon, A Thompson, et al.The Cochrane Database of Systematic Reviews|May 5, 2000
Ketanserin for Raynaud's phenomenon in progressive systemic sclerosisJ Pope, D Fenlon, A Thompson, et al.Annals of the Rheumatic Diseases|January 29, 2005
Pharmacogenetic and metabolite measurements are associated with clinical status in patients with rheumatoid arthritis treated with methotrexate: results of a multicentred cross sectional observational studyT Dervieux, D Furst, D O Lein, et al.Pageof 5